These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8104882)

  • 61. Suppression of cytolytic T-lymphocyte responses through inactivation of non-T accessory cells.
    Degiovanni G
    Scand J Immunol; 1987 May; 25(5):453-60. PubMed ID: 3495867
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Galactose oxidation in the design of immunogenic vaccines.
    Zheng B; Brett SJ; Tite JP; Lifely MR; Brodie TA; Rhodes J
    Science; 1992 Jun; 256(5063):1560-3. PubMed ID: 1598588
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthetic peptide vaccines effective in preventing virus infection.
    Ogasawara K
    Microbiol Immunol; 1999; 43(10):915-23. PubMed ID: 10585138
    [No Abstract]   [Full Text] [Related]  

  • 64. Analysis of CD8 T-cell response by IFNgamma ELISPOT and H-2L(d)/pRL1a tetramer assays in pRL1a multiple antigen peptide-immunized and RL male 1-bearing BALB/c and (BALB/c x C57BL/6) F(1) mice.
    Takada I; Noguchi Y; Kenjo A; Wada H; Uenaka A; Fujita T; Inoue H; Nakayama E
    Cancer Sci; 2004 Mar; 95(3):254-9. PubMed ID: 15016326
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A subdominant CD8(+) cytotoxic T lymphocyte (CTL) epitope from the Plasmodium yoelii circumsporozoite protein induces CTLs that eliminate infected hepatocytes from culture.
    Franke ED; Sette A; Sacci J; Southwood S; Corradin G; Hoffman SL
    Infect Immun; 2000 Jun; 68(6):3403-11. PubMed ID: 10816491
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tat-mediated protein delivery can facilitate MHC class I presentation of antigens.
    Moy P; Daikh Y; Pepinsky B; Thomas D; Fawell S; Barsoum J
    Mol Biotechnol; 1996 Oct; 6(2):105-13. PubMed ID: 8970166
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preventive and therapeutic AIDS peptide vaccines.
    Rubinstein A; Cryz S
    Eur J Pediatr; 1995; 154(9 Suppl 4):S28-9. PubMed ID: 8529706
    [No Abstract]   [Full Text] [Related]  

  • 68. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.
    Vitiello A; Ishioka G; Grey HM; Rose R; Farness P; LaFond R; Yuan L; Chisari FV; Furze J; Bartholomeuz R
    J Clin Invest; 1995 Jan; 95(1):341-9. PubMed ID: 7814635
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
    Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM
    Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytotoxic T lymphocyte activation by cross-priming.
    Heath WR; Carbone FR
    Curr Opin Immunol; 1999 Jun; 11(3):314-8. PubMed ID: 10375548
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide.
    Nardelli B; Tam JP
    Immunology; 1993 Jul; 79(3):355-61. PubMed ID: 8104882
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Use of helper T cell-inducing peptides from conserved regions in HIV-1 env in a noncovalent mixture with a CTL-inducing V3-loop peptide for in vivo induction of long-lasting systemic CTL response.
    Nehete PN; Arlinghaus RB; Sastry KJ
    Viral Immunol; 1994; 7(4):189-97. PubMed ID: 7576033
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector.
    Carbonetti NH; Tuskan RG; Lewis GK
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):819-27. PubMed ID: 11429123
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans.
    Doe B; Steimer KS; Walker CM
    Eur J Immunol; 1994 Oct; 24(10):2369-76. PubMed ID: 7523139
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of macrophages in promoting the antibody response mediated by liposome-associated protein antigens.
    Shek PN; Lukovich S
    Immunol Lett; 1982; 5(6):305-9. PubMed ID: 6762337
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.